Socio-Demographic, Lifestyle, and Cardiometabolic Characteristics Associated with Low-Grade Systemic Inflammation in Russian Adult Population

Mortality from cardiovascular diseases (CVDs) is higher in Russia compared to other European countries. High-sensitivity C-reactive protein (hs-CRP) is a biomarker of inflammation, and its elevated levels indicate increased CVD risks. We aim to describe the prevalence of low-grade systemic inflammation (LGSI) and the associated factors in a Russian population. The Know Your Heart cross-sectional study was conducted in Arkhangelsk, Russia in 2015–2017 with a population sample aged 35–69 years (n = 2380). LGSI was defined as hs-CRP ≥ 2 and < 10 mg/L, and its associations with socio-demographic, lifestyle, and cardiometabolic characteristics were analyzed. The prevalence of LGSI (age-standardized to European Standard Population 2013) was 34.1% (33.5% in men and 36.1% in women). In the total sample, the increased odds ratios (ORs) of LGSI were associated with abdominal obesity (2.1), smoking (1.9), dyslipidemia (1.5), pulmonary diseases (1.4), and hypertension (1.3); the decreased ORs were in women (0.6) and in married participants (0.6). In men, the ORs were higher with abdominal obesity (2.1), smoking (2.0), CVDs (1.5), and hazardous drinking (1.5); in women—with abdominal obesity (4.4) and pulmonary diseases (1.5). In conclusion, one-third of the adult population in Arkhangelsk had LGSI. Abdominal obesity was the strongest LGSI correlate in both sexes, while the profiles of other associated factors were different between men and women.

[1]  Zenglei Zhang,et al.  Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets , 2023, Frontiers in Immunology.

[2]  P. Mathur,et al.  The influence of inflammation on cardiovascular disease in women , 2022, Frontiers in Global Women's Health.

[3]  Jau-Yuan Chen,et al.  The Association between High-Sensitivity C-Reactive Protein and Metabolic Syndrome in an Elderly Population Aged 50 and Older in a Community Receiving Primary Health Care in Taiwan , 2022, International journal of environmental research and public health.

[4]  Hequn Chen,et al.  Increased risk of testosterone deficiency is associated with the systemic immune-inflammation index: a population-based cohort study , 2022, Frontiers in Endocrinology.

[5]  M. Dichgans,et al.  Associations of genetically predicted IL-6 signaling with cardiovascular disease risk across population subgroups , 2022, BMC Medicine.

[6]  L. Rodríguez-Mañas,et al.  Effect of Physical Activity/Exercise on Oxidative Stress and Inflammation in Muscle and Vascular Aging , 2022, International journal of molecular sciences.

[7]  A. Krettek,et al.  Obesity Prevalence and Associated Socio-Demographic Characteristics and Health Behaviors in Russia and Norway , 2022, International journal of environmental research and public health.

[8]  Meera Shivasekar,et al.  Assessment of Remnant Lipoprotein Cholesterol and Oxidized Low density Lipoprotein Associated with Low-grade Inflammation in Coronary Heart Disease Subjects of Young South Indian Population. , 2022, The Journal of the Association of Physicians of India.

[9]  Roddy Hiram,et al.  Evidence of Failed Resolution Mechanisms in Arrhythmogenic Inflammation, Fibrosis and Right Heart Disease , 2022, Biomolecules.

[10]  Y. Nikolaev,et al.  C-reactive protein as an indicator of polymorbidity in patients with arterial hypertension , 2022, Сибирский научный медицинский журнал.

[11]  A. Eggen,et al.  Socioeconomic inequalities in physiological risk biomarkers and the role of lifestyles among Russians aged 35-69 years , 2022, International Journal for Equity in Health.

[12]  S. J. Sojourner,et al.  Smoking cessation reduces systemic inflammation and circulating endothelin-1 , 2021, Scientific Reports.

[13]  A. W. Kranjac,et al.  Deconstructing sex differences in C‐reactive protein trends over time , 2021, American journal of human biology : the official journal of the Human Biology Council.

[14]  S. Achenbach,et al.  Epidemiology of cardiovascular disease in Europe , 2021, Nature Reviews Cardiology.

[15]  F. Xue,et al.  Genetically Determined Chronic Low-Grade Inflammation and Hundreds of Health Outcomes in the UK Biobank and the FinnGen Population: A Phenome-Wide Mendelian Randomization Study , 2021, Frontiers in Immunology.

[16]  J. Lima,et al.  Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. , 2021, European heart journal.

[17]  T. Wilsgaard,et al.  Heavy alcohol drinking and subclinical echocardiographic abnormalities of structure and function , 2021, Open Heart.

[18]  С. А. Максимов,et al.  Связь высокочувствительного С-реактивного белка с фатальными и нефатальными сердечно-сосудистыми событиями у лиц трудоспособного возраста (данные проспективного исследования ЭССЕ-РФ) , 2021 .

[19]  O. Polyakova,et al.  Levels of high‑sensitivity C‑reactive protein in young and middle‑aged individuals and their association with hypertension , 2021 .

[20]  S. Wild,et al.  What factors explain the much higher diabetes prevalence in Russia compared with Norway? Major sex differences in the contribution of adiposity , 2021, BMJ Open Diabetes Research & Care.

[21]  A. Kucharska,et al.  Obesity and chronic inflammation crosslinking , 2021, Central-European journal of immunology.

[22]  M. Vaillant,et al.  Micronutrients and Markers of Oxidative Stress and Inflammation Related to Cardiometabolic Health: Results from the EHES-LUX Study , 2020, Nutrients.

[23]  S. Malyutina,et al.  [C-reactive protein and its associations with сardiometabolic risk factors and echocardiographic indicators of heart failure: results of "Know your heart" study in Arkhangelsk]. , 2020, Kardiologiia.

[24]  J. Ioannidis,et al.  Global assessment of C-reactive protein and health-related outcomes: an umbrella review of evidence from observational studies and Mendelian randomization studies , 2020, European Journal of Epidemiology.

[25]  Jian Huang,et al.  Distribution of High-sensitivity C-reactive Protein Status in an Urban Population in China. , 2020, Biomedical and environmental sciences : BES.

[26]  R. Keogh,et al.  Why does Russia have such high cardiovascular mortality rates? Comparisons of blood-based biomarkers with Norway implicate non-ischaemic cardiac damage , 2020, Journal of Epidemiology & Community Health.

[27]  G. Kitas,et al.  Exercise and inflammation. , 2020, Best practice & research. Clinical rheumatology.

[28]  Deepak L. Bhatt,et al.  Targeting cardiovascular inflammation: next steps in clinical translation. , 2020, European heart journal.

[29]  S. Bakri,et al.  The association between metabolic syndrome components, low-grade systemic inflammation and insulin resistance in non-diabetic Indonesian adolescent male. , 2020, Clinical nutrition ESPEN.

[30]  T. Wilsgaard,et al.  Evidence for a Direct Harmful Effect of Alcohol on Myocardial Health: A Large Cross‐Sectional Study of Consumption Patterns and Cardiovascular Disease Risk Biomarkers From Northwest Russia, 2015 to 2017 , 2019, Journal of the American Heart Association.

[31]  A. Maharani Socio-economic inequalities in C-reactive protein levels: Evidence from longitudinal studies in England and Indonesia , 2019, Brain, Behavior, and Immunity.

[32]  D. Levy,et al.  Sex Differences in Circulating Biomarkers of Cardiovascular Disease. , 2019, Journal of the American College of Cardiology.

[33]  Yi Wu,et al.  The Multiple Faces of C-Reactive Protein—Physiological and Pathophysiological Implications in Cardiovascular Disease , 2019, Molecules.

[34]  P. Vineis,et al.  Multi-cohort study identifies social determinants of systemic inflammation over the life course , 2019, Nature Communications.

[35]  T. Laatikainen,et al.  Laboratory test based assessment of WHO alcohol risk drinking levels , 2019, Scandinavian journal of clinical and laboratory investigation.

[36]  A. Palou,et al.  A Genetic Score of Predisposition to Low-Grade Inflammation Associated with Obesity May Contribute to Discern Population at Risk for Metabolic Syndrome , 2019, Nutrients.

[37]  S. Anton,et al.  Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis , 2018, Ageing Research Reviews.

[38]  Aditi Singh,et al.  OLR1 Gene Polymorphism and Oxidized LDL Levels in Metabolic Syndrome in Indian Population , 2018, Indian journal of endocrinology and metabolism.

[39]  A. Avan,et al.  Serum C‐reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice , 2018, Journal of cellular physiology.

[40]  T. Clark,et al.  Know Your Heart: Rationale, design and conduct of a cross-sectional study of cardiovascular structure, function and risk factors in 4500 men and women aged 35-69 years from two Russian cities, 2015-18. , 2018, Wellcome open research.

[41]  Carl A Latkin,et al.  The relationship between social desirability bias and self-reports of health, substance use, and social network factors among urban substance users in Baltimore, Maryland. , 2017, Addictive behaviors.

[42]  Yanwei Xing,et al.  Oxidative Stress-Mediated Atherosclerosis: Mechanisms and Therapies , 2017, Front. Physiol..

[43]  M. Kumari,et al.  Socio-economic inequalities in C-reactive protein and fibrinogen across the adult age span: Findings from Understanding Society , 2017, Scientific Reports.

[44]  A. Esteghamati,et al.  Distributions of High-Sensitivity C-Reactive Protein, Total Cholesterol-HDL Ratio and 10-Year Cardiovascular Risk: National Population-Based Study. , 2017, Acta medica Iranica.

[45]  C. Voermans,et al.  Remnant Cholesterol Elicits Arterial Wall Inflammation and a Multilevel Cellular Immune Response in Humans , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[46]  A. Khera,et al.  Sex-Based Differences in Cardiometabolic Biomarkers , 2017, Circulation.

[47]  K. Sun,et al.  Inflammatory biomarkers of coronary heart disease. , 2017, Frontiers in bioscience.

[48]  S. Costanzo,et al.  Relative contribution of health-related behaviours and chronic diseases to the socioeconomic patterning of low-grade inflammation , 2017, International Journal of Public Health.

[49]  V. Fuster,et al.  Oxidized LDL Is Associated With Metabolic Syndrome Traits Independently of Central Obesity and Insulin Resistance , 2016, Diabetes.

[50]  S. Gangemi,et al.  Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity , 2016, Archivum Immunologiae et Therapiae Experimentalis.

[51]  M. Fenech,et al.  Low-grade inflammation, diet composition and health: current research evidence and its translation , 2015, British Journal of Nutrition.

[52]  J. Goldstein,et al.  A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins , 2015, Cell.

[53]  O. Franco,et al.  Pleiotropy among Common Genetic Loci Identified for Cardiometabolic Disorders and C-Reactive Protein , 2015, PloS one.

[54]  S. Legrand-Poels,et al.  Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. , 2014, Diabetes research and clinical practice.

[55]  F. Hage C-reactive protein and Hypertension , 2014, Journal of Human Hypertension.

[56]  B. Nordestgaard,et al.  Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation , 2013, Circulation.

[57]  P. Barter,et al.  Trends in C-reactive protein levels in US adults from 1999 to 2010. , 2013, American journal of epidemiology.

[58]  L. Joseph,et al.  Obesity and C‐reactive protein in various populations: a systematic review and meta‐analysis , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[59]  H. Cai,et al.  Lifestyle determinants of C-reactive protein in middle-aged, urban Chinese men. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[60]  Salvatore Panico,et al.  Validity of a short questionnaire to assess physical activity in 10 European countries , 2011, European Journal of Epidemiology.

[61]  A. Verhoeff,et al.  Ethnic differences in systemic inflammation: an investigation of C-reactive protein levels among Moroccan, Turkish and Dutch groups in the Netherlands. , 2011, Atherosclerosis.

[62]  H. Pavenstädt,et al.  C-Reactive Protein Makes Human Endothelium Stiff and Tight , 2011, Hypertension.

[63]  L. Smeeth,et al.  Ancestry as a Determinant of Mean Population C-Reactive Protein Values: Implications for Cardiovascular Risk Prediction , 2010, Circulation. Cardiovascular genetics.

[64]  Hynek Pikhart,et al.  APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample , 2010, Human immunology.

[65]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[66]  Y. Shin,et al.  Gender difference and determinants of C-reactive protein level in Korean adults , 2009, Clinical chemistry and laboratory medicine.

[67]  Y. Ragino,et al.  Relationship between oxidized fibrinogen and hemostasis disturbances and endothelial dysfunction in myocardial infarction , 2008, Bulletin of Experimental Biology and Medicine.

[68]  Duk-Hee Lee,et al.  Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. , 2008, JAMA.

[69]  B. Uppal,et al.  Comparison of two methods of estimation of low density lipoprotein cholesterol, the direct versus friedewald estimation , 2005, Indian Journal of Clinical Biochemistry.

[70]  T. Jørgensen,et al.  The Dietary Quality Score: validation and association with cardiovascular risk factors: the Inter99 study , 2007, European Journal of Clinical Nutrition.

[71]  P. Ridker,et al.  Comparison of Interleukin-6 and C-Reactive Protein for the Risk of Developing Hypertension in Women , 2007, Hypertension.

[72]  R. Spitzer,et al.  The PHQ-9 , 2001, Journal of General Internal Medicine.

[73]  O. Nilssen,et al.  C-reactive protein and alcohol consumption: Is there a U-shaped association? Results from a population-based study in Russia. The Arkhangelsk study. , 2006, Atherosclerosis.

[74]  B. Löwe,et al.  A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.

[75]  S. Yusuf,et al.  C-Reactive Protein as a Screening Test for Cardiovascular Risk in a Multiethnic Population , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[76]  S. Verma,et al.  C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle , 2003, Circulation.

[77]  A. Mainous,et al.  Relation between alcohol consumption and C-reactive protein levels in the adult US population. , 2002, The Journal of the American Board of Family Practice.

[78]  Tzong-Shyuan Lee,et al.  Fas/Fas ligand-mediated death pathway is involved in oxLDL-induced apoptosis in vascular smooth muscle cells. , 2001, American journal of physiology. Cell physiology.

[79]  W. G. Wood,et al.  Evaluation of a sensitive immunoluminometric assay for the determination of C-reactive protein (CRP) in serum and plasma and the establishment of reference ranges for different groups of subjects. , 2000, Clinical laboratory.